New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain

Molecular Brain Research

Volumn 53, Issue 1-2, 1998, Pages 307-310

  Tief, Kirsten ^a   Schmidt, Andrea ^a   Beermann, Friedrich ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

galactosidase; Brain; Neuromelanin; Substantia nigra; Transgenic mouse; Tyrosinase

Indexed keywords

BETA GALACTOSIDASE; BRAIN ENZYME; MELANIN; MONOPHENOL MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; EMBRYO; EMBRYO DEVELOPMENT; ENZYME LOCALIZATION; EPITHALAMUS; FOREBRAIN; HIPPOCAMPUS; MELANOGENESIS; MESENCEPHALON; MOUSE; NEWBORN; NONHUMAN; OLFACTORY SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; SUBSTANTIA NIGRA; TRANSGENIC MOUSE;

ANIMALS; BETA-GALACTOSIDASE; BRAIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTRAMOLECULAR OXIDOREDUCTASES; MEMBRANE GLYCOPROTEINS; MESENCEPHALON; MICE; MICE, TRANSGENIC; MONOPHENOL MONOOXYGENASE; ORGAN SPECIFICITY; OXIDOREDUCTASES; PROMOTER REGIONS (GENETICS); PROSENCEPHALON; PROTEIN BIOSYNTHESIS; PROTEINS; RECOMBINANT FUSION PROTEINS; SUBSTANTIA NIGRA;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0031883023     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00301-X     Document Type: Article

References (24)

1. Barden H., Levine S. Histochemical observations on rodent brain melanin. Brain Res. Bull. 10:1983;847-851.
2. Battyani Z., Xerri L., Hassoun J., Bonerandi J., Grob J. Tyrosinase gene expression in human tissues. Pigment Cell Res. 6:1993;400-405.
3. Beermann F., Ruppert S., Hummler E., Bosch F.X., Müller G., Rüther U., Schütz G. Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice. EMBO J. 9:1990;2819-2826.
4. Beermann F., Schmid E., Schütz G. Expression of the mouse tyrosinase gene during embryonic development: recapitulation of the temporal regulation in transgenic mice. Proc. Natl. Acad. Sci. USA. 89:1992;2809-2813.
5. Boon T., Gajewski T., Coulie P. From defined human tumor antigens to effective immunization. Immunol. Today. 16:1995;334-336.
6. Conlee J., Parks T., Romero C., Creel D. Auditory brainstem anomalies in albino cats: II. Neuronal atrophy in the superior olive. J. Comp. Neurol. 225:1984;141-148.
7. Kastner A., Hirsch E., Lejeune O., Javoy-Agid F., Rascol O., Agid Y. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content. J. Neurochem. 59:1992;1080-1089.
8. Klein-Szanto A., Bradl M., Porter S., Mintz B. Melanosis and associated tumors in transgenic mice. Proc. Natl. Acad. Sci. USA. 88:1991;169-173.
9. Nagatsu T., Levitt M., Udenfried S. Tyrosine hydroxylase: the initial step in norepinephrine biosynthesis. J. Biol. Chem. 239:1964;2910-2917.
10. Pavan W.J., Tilghman S.M. Piebald lethal (sl) acts early to disrupt the development of neural crest-derived melanocytes. Proc. Natl. Acad. Sci. USA. 91:1994;7159-7163.
11. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1986.
12. Powell M., Hyman P., Bell O., Balmain A., Brown K., Alberts D., Bowden G. Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T24 Ha-ras gene regulated by a mouse tyrosinase promoter. Mol. Carcinogen. 12:1995;82-90.
13. Rice D., Williams R., Goldowith D. The consistent effect of null alleles at tyrosinase suggests a comparably tight linkage between the biochemical activity of this enzyme and the mechanisms that control decussation phenotype. J. Comp. Neurol. 354:1995;459-469.
14. Rodgers A., Curzon G. Melanin formation by human brain in vitro. J. Neurochem. 24:1975;1123-1129.
15. Rodriguez-Lopez J., Varon R., Garcia-Canovas F. Oxidation of 6-hydroxydopamine catalyzed by tyrosinase. Int. J. Biochem. 25:1993;1175-1182.
16. Rosengren E., Linder-Eliasson E., Carlsson A. Detection of 5-S-cysteinyldopamine in human brain. J. Neural Transm. 63:1985;247-253.
17. Slominski A., Paus R. Towards defining receptors for L-tyrosine and L-DOPA. Mol. Cell. Endocrinol. 99:1994;C7-C11.
18. Smith B., Selby P., Southgate J., Pittman K., Bradley C., Blair G.E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet. 338:1991;1227-1229.
19. Steel K.P., Davidson D.C., Jackson I.J. TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor. Development. 115:1992;1111-1119.
20. Tief K., Hahne M., Schmidt A., Beermann F. Tyrosinase, the key enzyme in melanin synthesis, is expressed in murine brain. Eur. J. Biochem. 241:1996;12-16.
21. Tief K., Schmidt A., Aguzzi A., Beermann F. Tyrosinase is a new marker for cell populations in the mouse neural tube. Dev. Dyn. 205:1996;445-456.
22. Vile R.G., Hart I.R. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res. 53:1993;3860-3864.
23. Xu Y., Stokes A., Freeman W., Kumer S., Vogt B., Vrana K. Tyrosinase mRNA is expressed in human substantia nigra. Mol. Brain Res. 45:1997;159-162.
24. Zecca L., Mecacci C., Seraglia R., Parati E. The chemical characterization of melanin contained in substantia nigra of human brain. Biochim. Biophys. Acta. 1138:1992;6-10.